Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
Smart Adaptive Artificial Channels Triggered by Hypoxia for Highly Selective Apoptosis in Cancer Cells
Qiuping Zhang1,2, Xiaopan Xie1,2, Qinghong Liang1,2
1Fujian Provincial Key Laboratory of Innovative Drug Target Research, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, 361102, China.
Researchers developed novel artificial ion channels that activate in low-oxygen cancer cells. These hypoxia-activated channels show enhanced cancer cell killing and selectivity, offering a promising new cancer therapy approach.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Biology
Background:
- Hypoxia-sensitive ion channels are crucial for cellular adaptation to low oxygen.
- Artificial ion channels lack stimuli-responsive properties seen in natural channels.
- Developing artificial channels that mimic natural functions is an ongoing challenge.
Purpose of the Study:
- To create novel adaptive artificial ion channels.
- To achieve hypoxia-inducible activation in cancer cells.
- To investigate the therapeutic potential of these channels.
Main Methods:
- Designed artificial channels with nitro/azo groups reducible under hypoxia.
- Utilized reductase-mediated reduction to release channel-forming units.
- Investigated channel assembly into chloride channels or nanopores.
- Assessed cytotoxicity and selectivity against liver cancer cells (HepG2).
Main Results:
- A novel class of artificial ion channels activated by hypoxia was developed.
- The C1 channel variant showed an 18.1-fold enhancement in cytotoxicity against HepG2 cells (IC50 = 2.9 µM).
- C1 demonstrated high selectivity for liver cancer cells over normal cells (selectivity index = 17.9).
Conclusions:
- Hypoxia-activated artificial ion channels represent a promising new strategy for cancer therapy.
- The developed channels exhibit potent and selective anticancer activity.
- This approach offers a significant advancement over existing treatments like doxorubicin.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Apoptosis
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Targeted Cancer Therapies
There are several types of targeted therapies against...

